₹-0.02
(Market cap
₹5 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
-7.9 %
-
ROCE
-2 %
-
Industry P/E
23.28
-
EV/EBITDA
-40.2
-
Debt to Equity
0
-
Book Value
₹0.5
-
EPS
₹-0
-
Face value
1
-
Shares outstanding
109,920,000
10 Years Aggregate
CFO
₹-0.29 Cr
EBITDA
₹-3.35 Cr
Net Profit
₹-6.93 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mavens Biotech
| -19.0 | -13.0 | -35.6 | -25.4 | -12.0 | -28.3 | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Commodities#
| 9.7 | 2.7 | -1.2 | 13.5 | 16.4 | 9.7 | 14.0 |
|
Company
|
2016
|
2015
|
2014
|
|---|---|---|---|
|
Mavens Biotech
| -4.9 | -19.2 | -22.4 |
|
BSE Sensex
| 1.9 | -5.0 | 29.9 |
|
BSE Commodities
| 31.8 | -13.7 | 28.2 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mavens Biotech
|
0.5 | 5.2 | 0.0 | -0.4 | 3.9 | -7.9 | -- | 0.3 |
| 421.6 | 16,899.5 | 20,123.1 | 1,860.4 | 12.0 | 19 | 8.8 | 1.5 | |
| 626.6 | 2,919.1 | 1,517.1 | 94.7 | -- | -- | 29.8 | 3.7 | |
| 580.1 | 8,527.7 | 8,410.0 | 1,029.0 | 11.1 | 11.7 | 8.2 | 0.9 | |
| 158.0 | 6,295.9 | 12,344.2 | 683.9 | 5.0 | 5.6 | 9.1 | 0.5 | |
| 67.4 | 1,090.2 | 2,442.3 | 71.0 | 3.4 | 134.9 | 15.4 | 13.3 | |
| 71.1 | 3,483.1 | 22,480.4 | 272.7 | 2.7 | 13.5 | 9.6 | 1.2 | |
| 165.9 | 17,213.5 | 23,447.1 | 1,072.2 | 8.0 | 16.4 | 16.1 | 2.4 | |
| 119.8 | 6,606.5 | 18,695.3 | 450.0 | 3.7 | 8.3 | 14.8 | 1.3 | |
| 69.1 | 1,404.1 | 3,024.1 | 162.3 | 7.3 | 15.4 | 6.9 | 1.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Mavens Biotech
Wholesale of agricultural raw materials and live animals
-
Incorporated
1981
-
Chairman
--
-
Managing Director
Jay Prakash
-
Headquarters
Kolkata, West Bengal
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Mavens Biotech
What is the current share price of Mavens Biotech Ltd Today?
The share price of Mavens Biotech Ltd is ₹0.47 (BSE) as of 07-Mar-2017 IST. Mavens Biotech Ltd has given a return of -12.01% in the last 3 years.
What is the current PB & PE ratio of Mavens Biotech Ltd?
Since, TTM earnings of Mavens Biotech Ltd is negative, P/E ratio is not available.
The P/B ratio of Mavens Biotech Ltd is 0.27 times as on 07-Mar-2017, a 85 discount to its peers’ median range of 1.80 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Mavens Biotech Ltd?
The 52-week high and low of Mavens Biotech Ltd are Rs -- and Rs -- as of 31-Aug-2026.
What is the market cap of Mavens Biotech Ltd?
Mavens Biotech Ltd has a market capitalisation of ₹ 5 Cr as on 07-Mar-2017. As per SEBI classification, it is a company.
Should I invest in Mavens Biotech Ltd?
Before investing in Mavens Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.